HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alkaloid delta agonist BW373U86 increases hypoxic tolerance.

Abstract
Activation of delta opioid receptors increases survival time during acute, lethal hypoxia in mice. delta Agonists therefore present a promising avenue for therapeutic application to reduce the morbidity and mortality associated with clinical hypoxia in settings such as drowning, head injury apnea, and complicated childbirths. However, most delta agonists now available are peptides, and may have limited clinical utility. In the present study, we evaluate the neuroprotective ability of an alkaloid delta agonist, BW373U86. Alkaloid compounds, due to increased stability and increased systemic distribution, may be more favorable for clinical use. We found that BW373U86, like the peptide delta agonist, DPDPE ([D-Pen2, D-Pen5]-enkephalin), increases survival time of mice during lethal hypoxia. The mechanism of neuroprotection induced by delta receptor activation appears to involve decreasing body temperature. Further, using selective opioid receptor antagonists, it appears that BW373U86 exerts these neuroprotective effects by acting at delta-opioid receptors.
AuthorsD M Bofetiado, K P Mayfield, L G D'Alecy
JournalAnesthesia and analgesia (Anesth Analg) Vol. 82 Issue 6 Pg. 1237-41 (Jun 1996) ISSN: 0003-2999 [Print] United States
PMID8638797 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzamides
  • Narcotic Antagonists
  • Piperazines
  • Receptors, Opioid, delta
  • Receptors, Opioid, kappa
  • Receptors, Opioid, mu
  • BW 373U86
  • norbinaltorphimine
  • Naltrexone
  • beta-funaltrexamine
Topics
  • Acute Disease
  • Animals
  • Benzamides (pharmacology)
  • Body Temperature (drug effects)
  • Dose-Response Relationship, Drug
  • Hypoxia (drug therapy)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Naltrexone (analogs & derivatives, pharmacology)
  • Narcotic Antagonists (pharmacology)
  • Piperazines (pharmacology)
  • Receptors, Opioid, delta (agonists, antagonists & inhibitors)
  • Receptors, Opioid, kappa (antagonists & inhibitors)
  • Receptors, Opioid, mu (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: